1. Home
  2. FGEN vs SYPR Comparison

FGEN vs SYPR Comparison

Compare FGEN & SYPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FGEN
  • SYPR
  • Stock Information
  • Founded
  • FGEN 1993
  • SYPR 1997
  • Country
  • FGEN United States
  • SYPR United States
  • Employees
  • FGEN N/A
  • SYPR N/A
  • Industry
  • FGEN Biotechnology: Pharmaceutical Preparations
  • SYPR Industrial Machinery/Components
  • Sector
  • FGEN Health Care
  • SYPR Industrials
  • Exchange
  • FGEN Nasdaq
  • SYPR Nasdaq
  • Market Cap
  • FGEN 33.5M
  • SYPR 36.8M
  • IPO Year
  • FGEN 2014
  • SYPR 1994
  • Fundamental
  • Price
  • FGEN $0.30
  • SYPR $1.67
  • Analyst Decision
  • FGEN Strong Buy
  • SYPR
  • Analyst Count
  • FGEN 1
  • SYPR 0
  • Target Price
  • FGEN $10.00
  • SYPR N/A
  • AVG Volume (30 Days)
  • FGEN 594.8K
  • SYPR 11.8K
  • Earning Date
  • FGEN 05-12-2025
  • SYPR 05-23-2025
  • Dividend Yield
  • FGEN N/A
  • SYPR N/A
  • EPS Growth
  • FGEN N/A
  • SYPR N/A
  • EPS
  • FGEN N/A
  • SYPR N/A
  • Revenue
  • FGEN $6,996,000.00
  • SYPR $140,180,000.00
  • Revenue This Year
  • FGEN $232.81
  • SYPR N/A
  • Revenue Next Year
  • FGEN $9.16
  • SYPR N/A
  • P/E Ratio
  • FGEN N/A
  • SYPR N/A
  • Revenue Growth
  • FGEN N/A
  • SYPR 2.90
  • 52 Week Low
  • FGEN $0.18
  • SYPR $1.30
  • 52 Week High
  • FGEN $1.74
  • SYPR $3.72
  • Technical
  • Relative Strength Index (RSI)
  • FGEN 44.76
  • SYPR 52.23
  • Support Level
  • FGEN $0.29
  • SYPR $1.53
  • Resistance Level
  • FGEN $0.32
  • SYPR $1.68
  • Average True Range (ATR)
  • FGEN 0.02
  • SYPR 0.07
  • MACD
  • FGEN 0.00
  • SYPR 0.00
  • Stochastic Oscillator
  • FGEN 26.25
  • SYPR 77.78

About FGEN FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.

About SYPR Sypris Solutions Inc.

Sypris Solutions Inc is a USA-based company engaged in providing truck components, oil and gas pipeline components, and aerospace and defense electronics. The company offers a range of manufacturing, engineering, design, and other technical services. The business activity of the firm is functioned through Sypris Technologies and Sypris Electronics segments. Sypris Technologies segment is engaged in the sales of machined, welded, and heat-treated steel components for heavy commercial vehicle and high-pressure energy pipeline applications whereas the Sypris Electronics segment is engaged in the sale of manufacturing services, technical services, and products to customers in the market for aerospace and defense electronics. Sypris derives the revenue from the Technologies segment.

Share on Social Networks: